SCHEMBL4415548

SCHEMBL4415548

C#CCn1cccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6458837 0.71 SMN1; SMN2 (0.42)
SCHEMBL13560778 0.71
SCHEMBL1777628 0.69
SCHEMBL194207 0.69
SCHEMBL2330269 0.69
SCHEMBL10428444 0.66
SCHEMBL1245398 0.66
SCHEMBL1744917 0.66
SCHEMBL27308533 0.65
SCHEMBL13296357 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2794009-B1 BISARYLSULFONAMIDES USEFUL IN THE TREATMENT OF INFLAMMATION AND CANCER KANCERA AB (SE) 2017-08-30 EP claimed
EP-1200431-B3 QUINUCLIDINE DERIVATIVES AND THEIR USE AS MUSCARINIC M3 RECEPTORS LIGANDS ALMIRALL SA (ES) 2015-06-24 EP claimed
EP-1495002-B1 BENZAMIDE DERIVATIVES USEFUL AS HISTONE DEACETYLASE INHIBITORS ASTRAZENECA AB (SE) 2012-09-05 EP claimed
EP-2117709-A2 HYBRID MATERIAL, AND METHOD FOR THE PRODUCTION THEREOF UNIVERSITE PIERRE ET MARIE CURIE (FR) 2009-11-18 EP claimed
WO-2008129151-A2 HYBRID MATERIAL, AND METHOD FOR THE PRODUCTION THEREOF UNIVERSITE PIERRE ET MARIE CURIE (FR) 2008-10-30 WO claimed
EP-1471919-B1 PHARMACEUTICAL COMPOSITIONS COMPRISING 17ALPHA-FURANYLESTERS OF 17BETA-CARBOTHIOATE ANDROSTANES WITH A MUSCARINIC RECEPTOR ANTAGONIST GLAXO GROUP LTD (GB) 2005-08-10 EP claimed
EP-1200431-B1 QUINUCLIDINE DERIVATIVES AND THEIR USE AS MUSCARINIC M3 RECEPTORS LIGANDS ALMIRALL PRODESFARMA AG (CH) 2003-03-26 EP claimed
CN-104761544-B The selective depressant of the important mutant of clinic of EGFR tyrosine kinase 北京轩义医药科技有限公司 2019-03-15 CN disclosed
CN-104761544-A Selectivity inhibitor of EGFR tyrosine kinase clinic important mutant CS THERAPEUTICS INC 2015-07-08 CN disclosed
EP-2117709-A2 HYBRID MATERIAL, AND METHOD FOR THE PRODUCTION THEREOF UNIVERSITE PIERRE ET MARIE CURIE (FR) 2009-11-18 EP disclosed
US-7572753-B2 Tetrazole fungicides CHEMTURA CORPORATION (US) 2009-08-11 US disclosed
WO-2008129151-A2 HYBRID MATERIAL, AND METHOD FOR THE PRODUCTION THEREOF UNIVERSITE PIERRE ET MARIE CURIE (FR) 2008-10-30 WO disclosed
EP-1313725-B1 TRICYCLIC ANTITUMOR COMPOUNDS BEING FARNESYL PROTEIN TRANSFERASE INHIBITORS SCHERING CORP (US) 2007-04-11 EP disclosed
CN-1062071-A Contain the Pesticidal combination and the application thereof of new azole derivatives ROUSSEL UCLAF (FR) 1992-06-24 CN disclosed
CN-1015626-B Process for preparing novel pyrrole derivatives ROUSSEL UCLAF (FR) 1992-02-26 CN disclosed
EP-0176387-B1 PYRROLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR APPLICATION AS PESTICIDES ROUSSEL-UCLAF (FR) 1990-11-22 EP disclosed
US-4798901-A PESTICIDES; INSECTICIDES; PARACITICIDES; NEMATOCIDES; MITICIDES; VEGETABLES; VETERINARY MEDICINE Uclaf, Roussel (FR) 1989-01-17 US disclosed
US-4737513-A PESTICIDES ROUSSEL UCLAF (FR) 1988-04-12 US disclosed
CN-85106411-A Process for preparing novel pyrrole derivatives 1986-10-22 CN disclosed
EP-0176387-A1 Pyrrole derivatives, process for their preparation and their application as pesticides ROUSSEL-UCLAF (FR) 1986-04-02 EP disclosed